Genmab (GMAB) announced that the Japan Ministry of Health, Labour and Welfare has approved EPKINLY or epcoritamab, for the treatment of patients with relapsed or refractory or R/R, follicular ...
William Blair analyst Matthew Phipps last night upgraded Genmab (GMAB) to Outperform from Market Perform without a price target. after the ...
"With EPKINLY ® (epcoritamab) moving from strength to strength and two wholly owned assets, rinatabart sesutecan (Rina-Sâ„¢) and acasunlimab in Phase 3 development, we are confident in the ...
CEO Jan van de Winkel added, “With EPKINLY moving from strength to strength and two wholly owned assets, rinatabart sesutecan and acasunlimab in Phase 3 development, we are confident in the ...
Like Queen Elizabeth, she loves horses and a great tiara moment. Meghan Markle's refreshed lifestyle brand has a logo with a meaningful symbol. On Feb. 18, the Duchess of Sussex announced that she ...
With a portfolio of marketed products, including EPKINLY, TEPKINLY, and Tivdak, and a robust pipeline featuring Epcoritamab and tisotumab vedotin, it’s advancing groundbreaking treatments in ...
“With EPKINLY ® (epcoritamab) moving from strength to strength and two wholly owned assets, rinatabart sesutecan (Rina-Sâ„¢) and acasunlimab in Phase 3 development, we are confident in the potential of ...
Most products closed the year strong with Darzalex royalties leading the way. Epkinly net sales were $78 million, and this was slightly lower than expected due to one-time adjustments in France ...
The landing page revealed the As Ever logo, which PEOPLE understands is a tribute to Prince Harry. The logo incorporates a palm tree as a nod to the Duke and Duchess’s home in California ...